Peter Rahmer - Jan 29, 2024 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
Title: Chief Corporate Development Officer
Signature
/s/ Thomas Catinazzo, as Attorney-in-Fact
Stock symbol
RLAY
Transactions as of
Jan 29, 2024
Transactions value $
-$15,916
Form type
4
Date filed
1/31/2024, 04:14 PM
Previous filing
Jan 18, 2024
Next filing
Mar 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale -$15.9K -1.65K -0.32% $9.64 515K Jan 29, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,506 shares of restricted stock units ("RSUs") on January 27, 2024. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F2 Includes 471,840 shares underlying RSUs.

Remarks:

Title: Chief Corporate Development Officer